Search research articles
Contact Us
Filters
Showing results (121-130 of 133) with videos related to
Page
of 14
Sort By:
Bone Marrow Transplantation
|
March 3, 2016
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide
L Castagna, S Bramanti, S Furst, et al.
Bulletin Du Cancer
|
January 7, 2010
[Publication of biological samples collections catalogues by tumor banks]
C Chabannon, A Honstettre, L-M Daufresne, et al.
Bone Marrow Transplantation
|
February 20, 2025
The use of MSCs in steroid-refractory acute GvHD in Europe: a survey from the EBMT cellular therapy & immunobiology working party
L G M Daenen, L E van der Wagen, E F Bonneville, et al.
Bone Marrow Transplantation
|
November 24, 2015
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide
L Castagna, S Bramanti, S Furst, et al.
Bone Marrow Transplantation
|
January 17, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma
L Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation
|
May 4, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma
L Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation
|
March 22, 2016
The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide
R Crocchiolo, L Castagna, S Furst, et al.
Bone Marrow Transplantation
|
April 5, 2016
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation
L Boudin, A Gonçalves, R Sabatier, et al.
Bone Marrow Transplantation
|
January 17, 2017
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation
L Boudin, A Gonçalves, R Sabatier, et al.
Bone Marrow Transplantation
|
February 5, 2022
The first steps towards a diverse and inclusive EBMT: a position paper
S Montoto, J A Snowden, C Chabannon, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 133) with videos related to
Sort By:
Page
of 14
Bone Marrow Transplantation
|
March 3, 2016
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide
L Castagna, S Bramanti, S Furst, et al.
Bulletin Du Cancer
|
January 7, 2010
[Publication of biological samples collections catalogues by tumor banks]
C Chabannon, A Honstettre, L-M Daufresne, et al.
Bone Marrow Transplantation
|
February 20, 2025
The use of MSCs in steroid-refractory acute GvHD in Europe: a survey from the EBMT cellular therapy & immunobiology working party
L G M Daenen, L E van der Wagen, E F Bonneville, et al.
Bone Marrow Transplantation
|
November 24, 2015
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide
L Castagna, S Bramanti, S Furst, et al.
Bone Marrow Transplantation
|
January 17, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma
L Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation
|
May 4, 2017
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma
L Castagna, S Bramanti, R Devillier, et al.
Bone Marrow Transplantation
|
March 22, 2016
The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide
R Crocchiolo, L Castagna, S Furst, et al.
Bone Marrow Transplantation
|
April 5, 2016
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation
L Boudin, A Gonçalves, R Sabatier, et al.
Bone Marrow Transplantation
|
January 17, 2017
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation
L Boudin, A Gonçalves, R Sabatier, et al.
Bone Marrow Transplantation
|
February 5, 2022
The first steps towards a diverse and inclusive EBMT: a position paper
S Montoto, J A Snowden, C Chabannon, et al.
Page
of 14